NEW YORK (GenomeWeb News) – Response Biomedical said today that revenues in the third quarter increased 69 percent year over year.

Revenues in the quarter reached C$2.7 million (US$2.7 million), up from C$1.6 million a year ago. The firm said that cardiovascular sales rose 86 percent to C$2.6 million from C$1.4 million a year ago, driven primarily by business in China and Europe.

Its infectious disease, Bio-defense, and Environmental business, however, declined to C$85,000 from C$124,000 a year ago, a 31 percent drop.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.